Neuropharmacology of theophylline induced stuttering: the role of dopamine, adenosine and GABA
- 31 December 2005
- journal article
- Published by Elsevier in Medical Hypotheses
- Vol. 64 (2) , 290-297
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Translating A2Aantagonist KW6002 from animal models to parkinsonian patientsNeurology, 2003
- Stuttering: a dynamic motor control disorderJournal of Fluency Disorders, 2003
- Theophylline attenuates Ca2+ sensitivity and modulates BK channels in porcine tracheal smooth muscleBritish Journal of Pharmacology, 2003
- Adenosine A2A agonist CGS 21680 decreases the affinity of dopamine D2 receptors for dopamine in human striatumNeuroReport, 2001
- Theophylline‐induced stutteringMovement Disorders, 1998
- Features Resembling Tourette's Syndrome in Developmental StutterersBrain and Language, 1998
- Systemic and intrastriatal theophylline have opposite effects on dopamine and dopamine metabolites measured by intrastriatal microdialysis in the ratNeuroscience Letters, 1996
- The effect of theophylline on parkinsonian symptomsJournal of Pharmacy and Pharmacology, 1994
- Alleviation of acquired stuttering with human centremedian thalamic stimulation.Journal of Neurology, Neurosurgery & Psychiatry, 1989
- Theophylline reverses haloperidol-induced catalepsy in the rat possible relevance to the pharmacological treatment of psychosisBiological Psychiatry, 1988